Loading
Latest filing published 17 Feb 2026 for Envoy Medical, Inc., €105k.
Based on 5 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
All filings by Mona Chetan Patel on record concern Envoy Medical, Inc. The record holds 6 filings, for trades running from 9 September 2024 to 12 February 2026.
On the market, this insider has only ever bought: 6 purchases, €142k in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price. 2026 to date brings 1 purchase and no sales.
In size, the median ticket on the buying side is €8,735. Clusters matter here: 3 out of 6 purchases overlapped with buying by a colleague within 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. After 5 purchases with a full 90-day history, the hit rate stands at 0% and the median 90-day move at -11.7%. Past outcomes like these are no guarantee of what comes next.
The latest filing, published on 17 February 2026, reports an open-market purchase of €105k in Envoy Medical, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations